{
    "title": "Profit finally in sight for gene therapy specialist Oxford Bio",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4816352/Profit-finally-sight-gene-therapy-specialist-Oxford-Bio.html",
    "date": "2017-08-23",
    "keywords": [
        "gene",
        "bio",
        "therapy",
        "oxford",
        "novartis",
        "drug",
        "dawson",
        "year",
        "ctl019",
        "hirschler",
        "london",
        "profit",
        "cancer",
        "delivery",
        "company",
        "revenue",
        "september",
        "progress",
        "supply",
        "interest",
        "group",
        "market",
        "specialist",
        "biomedica",
        "success",
        "treatment",
        "manufacturer",
        "system",
        "slice",
        "payout",
        "dent",
        "path",
        "profitability",
        "tisagenlecleucel",
        "sale",
        "end",
        "approval",
        "research",
        "university",
        "haul",
        "funding",
        "story",
        "future",
        "chief",
        "executive",
        "john",
        "place",
        "companys",
        "road",
        "waxing",
        "waning",
        "field",
        "faulty",
        "dna",
        "safety",
        "chain",
        "depreciation",
        "amortisation",
        "half",
        "loss",
        "consensus",
        "analyst",
        "time",
        "lymphomas",
        "addition",
        "use",
        "leukaemia",
        "manufacturing",
        "partnership",
        "lure",
        "production",
        "reduction",
        "period",
        "doldrums",
        "percent",
        "optimism",
        "class",
        "cart",
        "antigen",
        "receptor",
        "tcell",
        "value",
        "minnow",
        "bluebird",
        "technology",
        "biotechnology",
        "europe",
        "function",
        "fact",
        "money",
        "decision",
        "development",
        "work",
        "pipeline",
        "ready",
        "pharma",
        "venture",
        "capital",
        "renaissance",
        "share"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}